Game-changing Strategies of European Pharma Companies

Game-changing Strategies of European Pharma Companies

Strong Focus on Digital Footprint and Beyond-the-pill Services Propel Companies to Innovate and Stay on the Growth Trajectory

RELEASE DATE
17-Jan-2017
REGION
Europe
Research Code: 9AB9-00-69-00-00
SKU: HC02715-EU-MR_19342

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
HC02715-EU-MR_19342

$1,500.00

$1,125.00 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing European pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights on the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalisation of key processes across drug development and manufacturing. It analyzes the dynamics catalyzing growth, profiles organizations presenting significant growth opportunities, and outlines innovative industry trends of key participants who play a vital role in the pharmaceutical landscape.

The research covers the top 5 European pharmaceutical companies, based on their industry position. The companies included in the study are Bayer, AstraZeneca, Roche, Novartis, and Sanofi. These companies are benchmarked across 5 key growth levers, namely core areas of focus, digital footprint, value chain excellence, strategic collaborations and partnerships, and beyond-the-pill services and solutions.

Highlights of the company profiles include:
•     Company snapshot
•     Performance analysis (market revenue forecast)
•     Portfolio analysis
•     Key marketed products and patent expiry
•     SWOT analysis
•     Strategic analysis of growth levers

Table of Contents

Executive Summary

Key Questions this Study will Answer

European Pharma Ecosystem

5 Big Themes for Innovation in European Pharma Companies

T10 European Pharma Companies

Strategic Collaborations/Alliances or Partnerships

Bayer Company Snapshot

Company Performance Analysis

Company Portfolio Analysis

Top 10 Marketed Products and Patent Expiries

Company SWOT Analysis

Strategic Analysis of Growth Levers

AstraZeneca Company Snapshot

Company Performance Analysis

Company Portfolio Analysis

Top 10 Marketed Products and Patent Expiries

Company SWOT Analysis

Strategic Analysis of Growth Levers

Novartis Company Snapshot

Company Performance Analysis

Company Portfolio Analysis

Top 10 Marketed Products and Patent Expiries

Company SWOT Analysis

Strategic Analysis of Growth Levers

Roche Company Snapshot

Company Performance Analysis

Company Portfolio Analysis

Top 10 Marketed Products and Patent Expiries

Company SWOT Analysis

Strategic Analysis of Growth Levers

Sanofi Company Snapshot

Company Performance Analysis

Company Portfolio Analysis

Top 10 Marketed Products and Patent Expiries

Company SWOT Analysis

Strategic Analysis of Growth Levers

The Last Word

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing European pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights on the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalisation of key processes across drug development and manufacturing. It analyzes the dynamics catalyzing growth, profiles organizations presenting significant growth opportunities, and outlines innovative industry trends of key participants who play a vital role in the pharmaceutical landscape. The research covers the top 5 European pharmaceutical companies, based on their industry position. The companies included in the study are Bayer, AstraZeneca, Roche, Novartis, and Sanofi. These companies are benchmarked across 5 key growth levers, namely core areas of focus, digital footprint, value chain excellence, strategic collaborations and partnerships, and beyond-the-pill services and solutions. Highlights of the company profiles include: • Company snapshot • Performance analysis (market revenue forecast) • Portfolio analysis • Key marketed products and patent expiry • SWOT analysis • Strategic analysis of growth levers
More Information
No Index No
Podcast No
Author Aarti Chitale
Industries Healthcare
WIP Number 9AB9-00-69-00-00
Is Prebook No